Triacetoxyperiodinane → HCID 23077588, compound
Reaction equation
[CH2:1]([O:8][C:9]1[C:10](=[O:31])[CH:11]=[C:12]([CH2:29][OH:30])[N:13]2[CH2:18][CH2:17][N:16]([CH2:19][C:20]3[CH:25]=[CH:24][C:23]([Cl:26])=[C:22]([Cl:27])[CH:21]=3)[C:15](=[O:28])[C:14]=12)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O>C(Cl)(Cl)Cl>[CH2:1]([O:8][C:9]1[C:10](=[O:31])[CH:11]=[C:12]([CH:29]=[O:30])[N:13]2[CH2:18][CH2:17][N:16]([CH2:19][C:20]3[CH:25]=[CH:24][C:23]([Cl:26])=[C:22]([Cl:27])[CH:21]=3)[C:15](=[O:28])[C:14]=12)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 9-benzyloxy-2-(3,4-dichlorobenzyl)-6-hydroxymethyl-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione (860 mg) obtained in Example 5, Step 6 in chloroform (80 ml) was added Dess-Martin reagent (843 mg). After stirring at room temperature for 1 hr, the solvent was evaporated and chloroform (50 ml) was added to the obtained residue and a solid product was filtered off. The filtrate was concentrated and purified by silica gel column chromatography (chloroform:acetone=1:2) to give 9-benzyloxy-2-(3,4-dichlorobenzyl)-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-6-carbaldehyde (621 mg).
Workup
- customthe solvent was evaporated
- additionchloroform (50 ml) was added to the obtained residue
- filtrationa solid product was filtered off
- concentrationThe filtrate was concentrated
- custompurified by silica gel column chromatography (chloroform:acetone=1:2)
Sources & evidence
- ORD record
- ord-1bcc68c524f6414c9434af94b5a31b15
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07211572B2
Reaction notes
Loading…